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ssembly of specialized membrane domains, both of
the plasma membrane and of the ER, is necessary
for the physiological activity of striated muscle cells.
The mechanisms that mediate the structural organization of
the sarcoplasmic reticulum with respect to the myoﬁbrils
are, however, not known. We report here that ank1.5, a
 
small splice variant of the 
 
ank1
 
 gene localized on the
sarcoplasmic reticulum membrane, is capable of interacting
with a sequence of 25 aa located at the COOH terminus of
obscurin. Obscurin is a giant sarcomeric protein of 
 
 
 
800
kD that binds to titin and has been proposed to mediate
interactions between myoﬁbrils and other cellular structures.
 
The binding sites and the critical aa required in the interaction
between ank1.5 and obscurin were characterized using the
yeast two-hybrid system, in in vitro pull-down assays and
in experiments in heterologous cells. In differentiated skeletal
muscle cells, a transfected myc-tagged ank1.5 was found
to be selectively restricted near the M line region where it
colocalized with endogenous obscurin. The M line local-
ization of ank1.5 required a functional obscurin-binding
site, because mutations of this domain resulted in a diffused
A
 
distribution of the mutant ank1.5 protein in skeletal muscle
cells. The interaction between ank1.5 and obscurin represents
the ﬁrst direct evidence of two proteins that may provide a
direct link between the sarcoplasmic reticulum and myoﬁbrils.
In keeping with the proposed role of obscurin in mediating
an interaction with ankyrins and sarcoplasmic reticulum,
we have also found that a sequence with homology to the
obscurin-binding site of ank1.5 is present in the ank2.2
isoform, which in striated muscles has been also shown to
associate with the sarcoplasmic reticulum. Accordingly, a
peptide containing the COOH terminus of ank2.2 fused
with GST was found to bind to obscurin. Based on reported
evidence showing that the COOH terminus of ank2.2 is
necessary for the localization of ryanodine receptors and
InsP
 
3
 
 receptors in the sarcoplasmic reticulum, we propose
that obscurin, through multiple interactions with ank1.5
and ank2.2 isoforms, may assemble a large protein complex
that, in addition to a structural function, may play a role in
the organization of speciﬁc subdomains in the sarcoplasmic
reticulum.
 
Introduction
 
The subcellular localization of the endosarcoplasmic reticulum
represents a central point in the biology of striated muscle
cells (Golovina and Blaustein, 1997; Meldolesi and Pozzan,
1998; Petersen et al., 2001). This issue, which is certainly
relevant to the structural organization of all eukaryotic cells,
is obviously even more relevant to muscle cells because of
the high level of specialization of the sarcoplasmic reticulum
in the latter ones (Franzini-Armstrong, 1994; Flucher and
Franzini-Armstrong, 1996; Baumann and Walz, 2001). In
striated muscles, the sarcoplasmic reticulum, which is spe-
 
cialized in storage, release, and reuptake of Ca
 
2
 
 
 
 (Berridge et
al., 2000), maintains a highly organized relationship with
respect to the contractile apparatus (Epstein and Fischman,
1991; Franzini-Armstrong, 1994). To perform its functions,
the sarcoplasmic reticulum forms a sleeve-like structure of
intracellular membranes organized around each myofibril.
The highly regulated nature of the arrangement of the sarco-
plasmic reticulum around myofibrils is such that specific
domains of the sarcoplasmic reticulum involved in the
 
mechanisms of Ca
 
2
 
 
 
 release and uptake (i.e., terminal cisternae
and longitudinal tubules, respectively) are distributed with a
regular spacing in correspondence to specific regions of the
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sarcomere (Franzini-Armstrong, 1994). The localization of
the sarcoplasmic reticulum in respect to myofibrils is highly
relevant to muscle cell physiology, considering that terminal
cisternae need to make contact with the t tubule/plasma
membrane to contribute to forming specific structures like
diads, triads, or peripheral couplings, which underlie the
process of excitation–contraction coupling in striated mus-
cles (Franzini-Armstrong, 1994; Flucher and Franzini-Arm-
strong, 1996). In contrast to the large body of evidence in
support of the importance of the intracellular organization
of the sarcoplasmic reticulum with respect to myofibrils, the
molecular mechanism(s) responsible for the interactions be-
tween these two cellular structures is not known.
Ankyrins are a family of proteins involved in the organi-
zation of specific membrane domains by mediating the
interactions between proteins of the plasma membrane
and the subplasma membrane cytoskeleton (Bennett and
Baines, 2001). In the past years, specific ankyrin isoforms
have been found to associate also with the membrane of in-
tracellular organelles such as the Golgi apparatus and lyso-
somes (Peters et al., 1995; Devarajan et al., 1996; Beck et
al., 1997; Hoock et al., 1997). In striated muscles, ankyrins
have been detected at specific sites, including costameres,
the postsynaptic membrane, and triads (Pardo et al., 1983;
Flucher et al., 1990; Bennett and Baines, 2001). Interest-
ingly, in addition to conventional ankyrins, muscle-specific
ankyrin isoforms have also been described. While some of
these muscle-specific ankyrin isoforms seem only to interact
with the membrane of the sarcoplasmic reticulum (Kordeli
et al., 1998; Gagelin et al., 2002), a group of striated mus-
cle–specific isoforms of the 
 
ank1
 
 gene (ank1.5, ank1.6, and
ank1.7) are selectively localized on the sarcoplasmic reticu-
lum membrane, with which they are associated through a
hydrophobic sequence located at their NH
 
2
 
-terminal region
(Zhou et al., 1997; Birkenmeier et al., 1998; Gallagher and
Forget, 1998). Recent studies with 
 
ank2
 
-deficient mice
have indicated that a
 
nk2
 
 may be important for the localiza-
tion of proteins involved in Ca
 
2
 
 
 
 homeostasis, such as ryan-
odine receptors and InsP
 
3
 
 receptors at specific domains of
the sarcoplasmic reticulum (Tuvia et al., 1999; Mohler et
al., 2002). Obscurin is a recently identified muscle protein
known to bind to titin (Bang et al., 2001; Young et al.,
2001; Russell et al., 2002). Obscurin is an extremely large
protein characterized by a modular architecture that con-
tains multiple Ig-like domains, two fibronectin (FN3)-like
domains, and a RhoGEF/PH domain. Additional tran-
scripts apparently derived from the obscurin gene have also
been detected. These transcripts contain one or two serine-
threonine kinase domains (Bang et al., 2001; Russell et al.,
2002). Whether the sequence encoding these kinase do-
mains can be associated with the initial obscurin transcript
(Young et al., 2001) is, however, not yet clear. Altogether,
the modular structure of obscurin makes this protein a very
good candidate for mediating multiple interactions between
the myofibrils and other cellular structures, including the
extramyofibrillar cytoskeleton (Stromer, 1998; Gregorio
and Antin, 2000; Bang et al., 2001; Young et al., 2001).
We report here that the ank1.5 isoform is capable of inter-
acting with the COOH terminus of obscurin. The interac-
tion between ank1.5 and obscurin is mediated by an aa se-
 
quence present in ank1.5, but not in ank 1.6 and ank1.7,
that recognizes a specific sequence present in the nonmodu-
lar region at the COOH terminus of obscurin. Mutations of
specific aa in these regions abolished binding between ank1.5
and obscurin. In addition to in vitro studies, the interaction
between ank1.5 and obscurin was also verified in heterolo-
gous cells transfected with plasmids encoding ank1.5 and a
fusion protein consisting of the COOH terminus of ob-
scurin cloned in frame with GFP. In agreement with in vitro
data, transfection of ank1.5 resulted in the association of
GFP–obscurin with the ER. Experiments performed in cul-
tured skeletal muscle cells revealed that ank1.5 is present
near or at the M line, where it colocalizes with obscurin. Lo-
calization of ank1.5 at the M line required the obscurin-
binding site because a mutation in this site prevented the lo-
calization of ank1.5 at the M line and resulted in a diffuse
distribution of the mutated protein. Based on the ability of
ank1.5 to specifically interact with a region at the COOH
terminus of obscurin, we propose that these two proteins
may contribute to hold a stable interaction between the sar-
coplasmic reticulum and the myofibrils. In line with the
above results, we have also found that, in addition to ank1.5,
the ank2.2 isoform can interact with obscurin through a se-
quence homologous to that present in ank1.5. In light of the
evidence that a
 
nk2
 
 is necessary for the localization of ryano-
dine receptors and InsP
 
3
 
 receptors (Tuvia et al., 1999; Mohler
et al., 2002), our working hypothesis envisions that obscurin
plays a role in assembling a scaffold of proteins important to
establish an association between the sarcoplasmic reticulum
and the cytoskeleton and to redistribute proteins, e.g., ryano-
dine receptors, InsP
 
3
 
 receptors, and eventually other pro-
teins, at specific domains of the sarcoplasmic reticulum.
 
Results
 
ank1.5 binds to a COOH-terminal fragment 
of obscurin in two-hybrid experiments
 
To identify potential interaction partners for short isoforms
of the 
 
ank1
 
 gene, a human skeletal muscle cDNA library was
screened using the yeast two-hybrid technique and the cyto-
plasmic tail of the ank1.5 cDNA as bait. Screening of a total
of 5 
 
 
 
 10
 
5
 
 clones resulted in the identification of seven pos-
itive colonies (A7, A14, A19, A26, A36, A62, and A38).
DNA sequencing revealed that all clones corresponded to
overlapping fragments of obscurin, a giant muscle protein
associated with the myofibrils (Bang et al., 2001; Young et
al., 2001). Obscurin has a modular architecture containing
multiple Ig-like domains, two fibronectin (FN3)-like do-
mains, and a RhoGEF/PH domain followed at the COOH
terminus by a nonmodular sequence (Fig. 1 A). Five of the
clones identified in the two-hybrid screening (A7, A14, A19,
A26, and A36) contained totally or partially the RhoGEF/
PH and two Ig-like domains, whereas clones A38 and A62
contained only the nonmodular sequence at the COOH ter-
minus (Fig. 1 A). None of these clones contained the kinase
domains identified by Bang et al. (2001) and Russell et al.
(2002). Because all clones can interact with ank1.5, we con-
cluded that the interaction site was located in the nonmodu-
lar sequence at the COOH terminus of obscurin, down-
stream of aa 6235.T
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Identification of the ank1.5 binding site in obscurin
 
Two-hybrid and pull-down experiments performed with
small fragments of the COOH terminus of obscurin identi-
fied a 118-aa fragment (aa 6236–6353) that was still capable
to interact with ank1.5 (Fig. 1 B). Characterization of a sec-
ond set of obscurin fragments restricted the domain in the
COOH-terminal region of obscurin capable of mediating
the interaction with ank1.5 to a minimal region of 25 aa
(residues 6236–6260) (Fig. 1 C). Site-directed mutagenesis
of these 25 aa indicated that the substitution of three threo-
nine residues (T6238, T6240, and T6241) drastically im-
paired the ability of obscurin to bind to ank1.5 (Fig. 1 D).
Mutation of other aa in this region did not significantly af-
fect the binding of the two proteins (unpublished data).
 
ank1.5, but not ank1.6 and ank1.7, binds to the COOH 
terminus of obscurin
 
To identify the sequence in ank1.5 responsible for the inter-
action with the COOH terminus of obscurin, we performed
experiments designed to test the ability of the three small
ankyrin isoforms (ank1.5, ank1.6, and ank1.7) to bind to the
COOH terminus of obscurin. Two-hybrid experiments were
performed using the cytosolic sequences of the ank1.5,
ank1.6, and ank1.7 isoforms (cloned in the pGBKT7 vector
as a bait) against the obscurin subclone A7 (cloned in the
pACT2 vector). Both the ability to grow in selective media
lacking histidine and 
 
 
 
-galactosidase activity indicated that
only ank1.5, not ank1.6 or ank1.7, was capable of binding
the COOH terminus of obscurin (Fig. 2 A). From a quanti-
tative point of view, it is worth noting that whereas the inter-
action of obscurin subclone A7 with ank1.5 yielded a very
strong blue reaction in the 
 
 
 
-galactosidase assay, interaction
with ank1.6 and ank1.7 did not result in any activity at all. In
parallel, pull-down experiments were performed using in
vitro–translated obscurin subclone A7 and GST fusion pro-
teins of the three ankyrin isoforms. As shown in Fig. 2 A, in
agreement with two-hybrid results, binding to the GST–ob-
scurin clone A7 was observed with ank1.5 and not with
ank1.6 or ank1.7. The alignment of aa sequences of muscle-
specific small ank1 isoforms revealed that ank1.5 contains a
stretch of 22 aa (aa 102–123) that is absent in ank1.6 and
ank1.7, suggesting that this region is involved in mediating
the binding of ank1.5 with the COOH terminus of obscurin.
 
ank2.2 binds to the COOH terminus of obscurin 
through a sequence homologous to that of ank1.5
 
Interestingly, the 22-aa sequence present in ank1.5, but not
in ank1.6 and ank1.7, is present also in the long ank1 iso-
forms and displays a high degree of homology with a region
present also in the COOH-terminal region of long ankyrin
products of the 
 
ANK2
 
 gene (Bennett and Baines, 2001) and
of a recently identified muscle-specific isoform (AnkG107)
of the 
 
ANK3
 
 gene (Gagelin et al., 2002) (Fig. 2 B). Recent
work in mice deleted of the 
 
ank2
 
 gene revealed that these
Figure 1. Association of ank1.5 with the COOH-terminal region of obscurin. (A) Two-hybrid screening with the cytosolic tail of ank1.5 
(aa 22–155) as “bait” identified seven positive clones, corresponding to the COOH terminus of the obscurin protein. (B) Fragments of the 
obscurin clone A7 were tested for the ability to interact with the bait ank1.5 in the two-hybrid system and with a GST–ank1.5 fusion protein 
in pull-down experiments. Both experiments demonstrated that the region of obscurin between aa 6236 and 6353 is capable to interact with 
ank1.5.  , detectable activity;  , no detectable activity. (C) A second series of obscurin fragments was prepared to further restrict the sequence 
responsible for binding with ank1.5 to 25 aa of obscurin (aa 6236–6260). (D) Mutagenesis of the aa in the COOH terminus of obscurin 
(aa 6236–6260) capable of mediating binding to ank1.5 was performed and mutant proteins were tested against GST–ank1.5 in in vitro 
binding assays.T
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mice, among other defects, present a displacement of some
specific proteins, such as ryanodine receptors and InsP
 
3
 
 re-
ceptors, from their normal sites in the sarcoplasmic reticu-
lum in striated muscles (Tuvia et al., 1999). Rescue experi-
ments of 
 
ank2
 
 
 
/
 
 
 
 mice have been performed using chimeric
proteins containing different regions of ank2 (AnkB220)
and ank3 (AnkG190) (Mohler et al., 2002). These ex-
periments revealed that the COOH-terminal region of
ank2 was required for correct localization of ryanodine and
InsP
 
3
 
 receptors in the sarcoplasmic reticulum of myocytes
from 
 
ank2
 
 
 
/
 
 
 
 mice. Because the COOH terminus of the
AnkB220 isoform of ank2, but not that of the AnkG190
isoform of ank3, contains the region of homology with
ank1.5, we decided to investigate whether the long isoform
ank2.2 could also bind to obscurin. Therefore, the last 115
aa at the COOH terminus of the long isoform ank2.2 (aa
1758–1872), which contains the region of homology with
ank1.5, were fused to GST and the resulting GST–ank2.2
fusion protein was used in pull-down experiments with an in
vitro–translated fragment of obscurin containing the region
between aa 6041–6620 (obscurin subclone A7). As shown in
Fig. 2 C, the GST fusion protein containing the COOH
terminus of ank2 was found to bind to the in vitro–trans-
lated obscurin subclone A7.
 
Identification of critical aa in ank1.5 required 
for interaction with obscurin
 
Alignment of aa sequences from ank1.3, ank2.2, and the
muscle-specific ank3 isoform (AnkG107) with the aa se-
quence of ank1.5 involved in binding to obscurin reveals the
presence of some conserved residue among these proteins.
To identify the critical aa that in ank1.5 are required for the
interaction with the COOH terminus of obscurin, site-
directed mutagenesis of aa 97–123 of ank1.5 was performed,
and the in vitro–transcribed and –translated mutant proteins
were used in binding experiments with the GST–Obs6215–
6353 fusion protein. As shown in Fig. 2 D, these experi-
ments identified four residues (T99, K101, R104, and
K105) that, if mutated (T99P, K101E, R104G, and
K105E), strongly reduced binding of in vivo–translated ob-
scurin subclone A7 to the GST–ank1.5 fusion protein. Con-
temporary mutagenesis of three of these aa residues (T99P,
K101E, and R104G) completely abolished the residual
binding observed in proteins containing only one mutated
aa (Fig. 2 D).
 
Fusion proteins containing the COOH terminus 
of obscurin can bind ank1.5 from transfected cells 
and skeletal muscle microsomes
 
To further expand on the interaction between ank1.5 and
the COOH-terminal part of obscurin, human embryonic
kidney (HEK)* 293 cells were transfected with myc-tagged
plasmids encoding full-length ank1.5 or ank1.7 cDNAs.
Microsomes prepared from transfected cells were solubilized
and the resulting supernatant was allowed to interact with a
fusion protein containing aa 6215–6353 of obscurin in
frame with GST. Western blot with anti-myc monoclonal
antibodies revealed that ank1.5, but not ank1.7, expressed in
HEK293 cells was retained by the GST–obscurin fusion
protein (Fig. 3 A). Previous work had shown that ank1.5 is a
membrane protein of the sarcoplasmic reticulum (Zhou et
al., 1997). To further examine the localization of ank1.5 in
the sarcoplasmic reticulum, skeletal muscle microsomes were
further fractionated according to established procedures
 
*Abbreviations used in this paper: HEK, human embryonic kidney;
MBP, maltose binding protein.
Figure 2. The site in ank1.5 able to interact with obscurin is 
located in a sequence highly conserved among ankyrins. (A) A 
schematic representation of the structure of the small muscle–specific 
ankyrin isoforms is presented: a color code identifies the different 
exons that, by undergoing alternative splicing, generate the different 
ank1 isoforms. The cytosolic sequences of ank1.5, ank1.6, and 
ank1.7 were used as baits in two-hybrid system experiments against 
the obscurin subclone A7. In parallel, in vitro–translated obscurin 
subclone A7 was allowed to interact with GST–ank1.5, GST–ank1.6, 
and GST–ank1.7. Both two-hybrid and in vitro binding assays 
demonstrated that only ank1.5 is capable of binding the obscurin 
subclone A7.  , detectable activity;  , no detectable activity. 
(B) The alignment of COOH-terminal sequences of a skeletal 
muscle–specific ank3 isoform (AnkG107), ank2.2, ank1.3, and 
ank1.5. Conserved aa residues are in bold. (C) In vitro binding 
of a GST fusion protein containing the COOH-terminal region of 
ank2.2 (aa 1758–1872) against in vitro–transcribed and –translated 
obscurin clone A7. (D) Site-directed mutagenesis of aa 97–123 of 
ank1.5 was performed and the in vitro–transcribed and –translated 
mutant proteins were used in binding experiments with the GST–
Obs6215–6353 fusion protein. Mutagenesis of any of four aa residues 
(T99, K101, R104, and K105) of ank1.5 strongly reduced the ability 
to bind to obscurin.T
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(Saito et al., 1984). Selected fractions, enriched in terminal
cisternae and longitudinal tubules, were analyzed by West-
ern blot with a rabbit antibody against ank1.5. A major
band of an apparent molecular mass of 25 kD, which is
compatible with the expected size of ank1.5, was found in
fractions of the sarcoplasmic reticulum containing longitu-
dinal tubules and terminal cisternae (Fig. 3 B). Using the
ank1.5 antiserum, endogenous ank1.5 solubilized from skel-
etal muscle sarcoplasmic reticulum was found to bind to the
maltose binding protein (MBP)–obscurin (aa 6215–6351)
fusion protein, but not to MBP alone (Fig. 3 C).
 
The COOH terminus of obscurin binds 
to the ER of heterologous cells expressing ank1.5
 
To study at the cellular level the interaction between ank1.5
and the COOH-terminal region of obscurin, an expression
vector encoding a fusion protein made of GFP followed by
the obscurin subclone A7 (GFP–ObsA7) was transfected
into NIH 3T3 cells in the absence or in the presence of ex-
pression vectors encoding ank1.5, ank1.7, or a mutant
ank1.5 unable to bind to obscurin. In transfected cells,
ank1.5 or ank1.7 presented a staining corresponding to that
of the ER compartment of the cells (Fig. 4, B, E, and H).
On the contrary, the GFP–ObsA7 protein, when expressed
alone, displayed a diffused cytosolic localization (unpub-
lished data). In cells cotransfected with ank1.5, the GFP–
ObsA7 staining was redistributed almost completely to the
same sites where ank1.5 was present (Fig. 4, A–C). The
specificity of this interaction was confirmed by the lack of
colocalization when GFP–ObsA7 was cotransfected with the
mutated version of ank1.5, which is unable to interact with
obscurin (Fig. 4, D–F). In addition, in agreement with pre-
vious results in yeast two-hybrid and pull-down experi-
ments, no colocalization was observed when ank1.7 was
transfected with the GFP–ObsA7 plasmid (Fig. 4, G–I).
 
ank1.5 colocalization with obscurin 
at the M line region of skeletal muscle cells
 
The evidence of a specific interaction between ank1.5 and
obscurin obtained in in vitro experiments and in heterolo-
gous cells opens the question of whether an interaction be-
tween these proteins occurs also in skeletal muscle cells. To
this end, cultures of differentiating primary skeletal muscle
cells were used as an experimental model. To verify the spe-
cific localization of the ank1.5 isoform, differentiating skele-
tal muscle cells were transfected with a plasmid encoding a
Figure 3. Exogenous and endogenous ank1.5 interacts with the 
COOH-terminal region of obscurin. (A) Microsomes from HEK293 
cells transfected with myc-tagged full-length cDNAs of ank1.5 and 
ank1.7 were used in interaction studies with the GST–Obs6215–
6353 fusion protein. (B) ank1.5 is present in the sarcoplasmic reticulum 
of skeletal muscle. ank1.5 reactivity was detected in the total 
microsomal fraction (lane 1), in sarcoplasmic reticulum fractions 
enriched in longitudinal tubules (lane 2), and in terminal cisternae 
(lane 3). No signal was detected by a preimmune sera when tested 
against the same preparations of the total microsomal fraction (lane 4), 
longitudinal tubules (lane 5), and terminal cisternae (lane 5). 
(C) Microsomes from mouse skeletal muscles were used as a source 
of endogenous ank1.5 to perform pull-down experiments against 
the MBP–Obs6215–6353 fusion protein.
Figure 4. Effect of ank1.5 on the local-
ization of obscurin in NIH 3T3 cells. 
NIH 3T3 cells were transfected with the 
obscurin subclone A7 joined in frame 
with GFP, the full-length cDNA of ank1.5, 
ank1.7, and mutant ank1.5 cloned in 
pcDNA3 vectors. Cells were decorated 
with anti-myc monoclonal antibodies 
and detected by a Cy3-conjugated anti–
mouse antibody (red). Panels show 
representative sections from the top to 
bottom of the cells at  0.25- m intervals. 
Bar, 5  m.T
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myc-tagged ank1.5 cDNA. Immunofluorescence studies us-
ing anti-myc antibodies and antibodies against 
 
 
 
-actinin
yielded two distinct alternating signals, which are compati-
ble with the localization of ank1.5 near or at the M line (Fig.
5, A–C). In the original report on the localization of small
muscle–specific ank1 isoforms (Zhou et al., 1997), a signal
specific for the endogenous small ank1 isoforms was ob-
served at the Z line and M line in skeletal muscle sections.
This apparent discrepancy could be due to the transfection
strategy and the use of primary cell cultures in our experi-
mental approach. Alternatively, it could reflect a specific lo-
calization of ank1.5 with respect to other small ank1 iso-
forms, considering that Zhou et al. (1997) used a polyclonal
antibody raised against an aa sequence that is present in
ank1.5 but also in other small ank isoforms.
To localize endogenous obscurin protein, differentiated
skeletal muscle cells were immunostained with rabbit an-
tibodies raised against the COOH-terminal region of
obscurin. The immunostaining obtained with antibodies
against obscurin was found to alternate with that of 
 
 
 
-acti-
nin, which is compatible with the localization of obscurin at
or near the M line region (Fig. 5, D–F). Obscurin has been
shown to have a complex localization pattern in striated
muscle cells, where it appears to be located at the M line, al-
though Z line localization has also been observed (Bang et
al., 2001; Young et al., 2001). We have occasionally ob-
served an additional obscurin staining compatible with the
Z line region, but this is far less frequent and reproducible
than the M line region signal (unpublished data). On the
other hand, it should be stated that labeling of obscurin with
respect to the Z line and M line might vary depending on
the localization of the epitope recognized by the antibodies
(Young et al., 2001; Bang et al., 2001). At the same time, al-
ternative splicing of obscurin could also affect the recogni-
tion by different antibodies (Bang et al., 2001; Russell et al.,
2002). Double staining of skeletal muscle cells with antibod-
ies against the myc-tagged ank1.5 and against endogenous
obscurin indicated that the two proteins colocalize (Fig. 5,
G–I). The colocalization of ank1.5 with obscurin was also
observed by transfection of a plasmid encoding a soluble
ank1.5 protein lacking the transmembrane domain (Fig. 5,
J–L), which suggests that the colocalization of ank1.5 with
obscurin does not require sarcoplasmic reticulum localiza-
tion of the former protein.
Interestingly, the localization of ank1.5 near the M line was
only observed in fully differentiated skeletal muscle cells; in
nondifferentiated cells, transfected ank1.5 appeared to have a
diffuse distribution, while obscurin-specific signal could not
be detected (unpublished data). Thus, the regular pattern of
ank1.5 observed in differentiated skeletal muscle cells might
Figure 5. Localization of ank1.5 and obscurin in differentiating skeletal muscle cells. Differentiated skeletal muscle cells were stained with 
rabbit antibodies against the myc epitope to recognize the myc-tagged ank1.5 protein (A) and with monoclonal antibodies against  -actinin, 
which stain the Z line (B). The alternating pattern of ank1.5 and  -actinin is compatible with the localization of ank1.5 near or at the M line. 
Cells were stained with rabbit antibodies against the COOH-terminal region of obscurin (D) and with monoclonal antibodies against  -actinin 
(E). Again, the obscurin staining is compatible with localization near or at the M line. Staining of the cells with antibodies against ank1.5 (G) 
and against obscurin (H) indicates that the two proteins colocalize. Soluble ank1.5 (ank1.5  TM) missing the transmembrane domain (K) is 
still able to colocalize with obscurin at the M line (L). A myc-tagged mutant ank1.5, unable to bind to obscurin, presents a diffuse signal (N) 
distinct from that of obscurin (M). Bar, 5  m.T
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depend on the expression of either obscurin or another pro-
tein regularly spaced near the M line. To more directly estab-
lish whether the observed colocalization of ank1.5 and ob-
scurin is mediated by a direct interaction between the two
proteins, a plasmid encoding full-length ank1.5 containing
three mutated aa residues in the domain required for in vitro
interaction with obscurin (ank1.5 mutTKR; Fig. 2) was
transfected in differentiating skeletal muscle cells. As shown
in Fig. 5 (M–O), mutation of the obscurin-binding site
of ank1.5 resulted in a diffuse distribution of ank1.5
upon transfection in skeletal muscle cells while obscurin sig-
nal maintained its regular sarcomeric arrangement. Conse-
quently, colocalization of ank1.5 with obscurin at the M line
required a functional obscurin-binding site.
 
Discussion
 
Striated muscle cells contain a highly developed and robust
system of protein–protein interactions, which guarantees
that the overall structure and integrity of muscle cells and
the subcellular localization of the various organelles is main-
tained independently of the morphological changes associ-
ated with contraction and relaxation cycles (Stromer, 1998;
Baumann and Walz, 2001; Bellin et al., 2001). In this con-
text, a central role is played by the dystrophin complex and
associated molecules that provide a robust scaffold that
holds the myofibrils, cytoskeleton, plasma membrane, and
extracellular matrix together (Blake et al., 2002). Among the
many structures that require a solid anchor in the dynamic
world of striated muscle cells are the highly sophisticated
membrane systems, which include the t tubule on the
plasma membrane and the different regions of the sarcoplas-
mic reticulum, which need to maintain contact among them
and with the myofilaments in order to allow the precise
transmission of signals that underlies the mechanism of exci-
tation–contraction (Flucher et al., 1993; Franzini-Arm-
strong, 1994). The existence of proteins necessary for the or-
ganization of these structures has been postulated and
heavily investigated for years (Stromer, 1998; Baumann and
Walz, 2001; Salanova et al., 2002). Significant develop-
ments in this field have been obtained recently with the dis-
covery of proteins like the junctophilins (Takeshima et al.,
2000; Ito et al., 2001) and MG29 (Nishi et al., 1999; Pan et
al., 2002), which represent interesting candidates for medi-
ating the interaction between the t-tubule/plasma mem-
brane and the sarcoplasmic reticulum. In addition, more re-
cently, an interaction between the minK subunit of the
delayed rectifier potassium current channel located on the t
tubule and the sarcomeric protein T-cap has also been re-
ported (Furukawa et al., 2001). However, as of today, noth-
ing is known about the identity of specific proteins responsi-
ble for the interaction between the sarcoplasmic reticulum
and the myofibrils.
Here we report that ank1.5, a muscle-specific ank1 iso-
form, which is an integral protein of the sarcoplasmic reticu-
lum of striated muscles, contains a specific domain capable
to selectively interact with the COOH-terminal part of ob-
scurin, a component of myofibrils. In agreement with data
on the characterization of the interaction between ank1.5
and obscurin obtained in vitro, we present evidence that
 
ank1.5 colocalizes with obscurin at the M line in differenti-
ated skeletal muscle cells. This localization appears to de-
pend on the integrity of the obscurin-binding site in ank1.5,
as shown by the lack of M line localization of a mutant
ank1.5 lacking the aa required for binding to obscurin.
These data therefore provide the first experimental evidence
of two proteins capable of mediating interactions between
the sarcoplasmic reticulum and the myofibrils. Considering
the complexity of the organization of the sarcoplasmic retic-
ulum network in striated muscle cells, several other proteins
are likely to participate in mediating the subcellular localiza-
tion/organization of the sarcoplasmic reticulum in muscle
cells. In this context, it is interesting to note that a sequence
with homology to the obscurin-binding site of ank1.5 is also
present in other ankyrin isoforms, namely the long ank1 iso-
form ank1.3, ank2.2, and the ank3 isoform AnkG107. A
role for ank2 in mediating the assembly of ryanodine and
InsP
 
3
 
 receptors at specific domains of the sarcoplasmic retic-
ulum of striated muscle cells has been reported (Tuvia et al.,
1999). The region of the ank2.2 protein necessary for the lo-
calization of calcium release channels in the sarcoplasmic
reticulum has been restricted to a small region at the
COOH terminus of ank2.2 (Mohler et al., 2002). We have
found that the COOH terminus of ank2.2 is capable of
binding to obscurin through a binding site homologous to
that of ank1.5. On this basis, we propose a model where the
interaction of obscurin with different ankyrin isoforms may
promote the assembly of a large protein complex, which, in
addition to supporting the association of the sarcoplasmic
reticulum with the myofibrils, may participate in the mecha-
nisms underlying the localization of Ca
 
2
 
 
 
 release channels
(i.e., ryanodine and InsP
 
3
 
 receptors), and eventually other
proteins, to specific domains of the sarcoplasmic reticulum.
Obviously more work is required for better defining the
complexity of these interactions.
 
Materials and methods
 
Construct preparations
 
The cDNAs of ank1.5, ank1.6, ank1.7 (GenBank/EMBL/DDBJ accession
nos. NM020478, NM020479, and NM020480) were amplified from a hu-
man skeletal muscle cDNA library (CLONTECH Laboratories, Inc.) by
PCR, using the following primers: 5
 
 
 
-AATGTGGACTTTCGTCACCCAG-
CTGTTGGT-3
 
 
 
 and 5
 
 
 
-CTGTTTCCCCCTTTTCAGGCTGGCCCGCTT-3
 
 
 
(ank1.5 and ank1.6) or 5
 
 
 
-GGGGTTGGGTGTCGAGGTGTGATCCTTCTT-
3
 
 
 
 (ank1.7). The cDNA corresponding to bp 5269–5616 of ank2 (se-
quence data available from GenBank/EMBL/DDBJ under accession no.
NM020977) was amplified using the following primer pair: 5
 
 
 
-ACTAT-
CATTTATGAAGGAGCCAAAATCCAC-3
 
 
 
 and 5
 
 
 
-CTCATTGTTGTCCT-
CTGACTGCTCGGTGTC-3
 
 
 
. The PCR products were inserted into
pGEMTeasy (Promega) and pcR2.1 (Invitrogen) cloning vectors. Expression
vectors for yeast, mammalian, and bacterial cells were pGBKT7 (Match-
maker system III; CLONTECH Laboratories, Inc.), pcDNA3.1 (Invitrogen),
pEGFP-C3 (CLONTECH Laboratories, Inc.), pGEX4T (Amersham Bio-
sciences), and pMAL-c2X (New England Biolabs, Inc.).
 
Yeast two-hybrid studies
 
The cDNA of ank1.5 (coding for aa 22–155) inserted into the pGBKT7 vec-
tor (Matchmaker system III) in fusion with GAL4-BD was used as bait to
screen a human skeletal muscle cDNA library fused with GAL4-AD in
pACT2 vector (CLONTECH Laboratories, Inc.). The 
 
Saccharomyces cerevi-
siae
 
 strain Y153 was cotransformed with the bait vector and the library-
derived plasmid as described by the manufacturer (Matchmaker system III).
5 
 
 
 
 10
 
5
 
 independent clones from a skeletal muscle cDNA library were
screened with the recombinant bait. The DNA of colonies positive for HIS3
activation and in 
 
 
 
-galactosidase assays was extracted and electroporatedT
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in 
 
Escherichia coli
 
 to select and isolate the library plasmids. All the clones
isolated were retransformed in yeast, and HIS3 activation and 
 
 
 
-galactosi-
dase assays were performed to confirm the interaction with the bait. Inter-
actions were further confirmed in two-hybrid assays by exchanging the bait
DNA-BD vector with the library-derived DNA-AD vector and vice versa.
 
Site-directed mutagenesis
 
To map the residues involved in ankyrin–obscurin interaction, ank1.5 (aa
22–155) and a portion of obscurin (aa 6215–6353) were used as templates
to perform site-directed mutagenesis using the QuickChange site-directed
mutagenesis kit (Stratagene) according to the manufacturer’s instructions.
 
Protein expression
 
All in vitro transcription and translation experiments were performed using
the TnT Quick Coupled Reticulocyte Lysate System as described by the
manufacturer (Promega). To label the peptides, the reactions were per-
formed in the presence of 
 
35
 
S 
 
L
 
-methionine (Amersham Biosciences). The
GST fusion proteins were obtained by cloning the cDNA of ank1.5 (aa 22–
155), ank1.6 (aa 22–133), ank1.7 (aa 22–109), ank2.2 (aa 1758–1872),
and obscurin (aa 6215–6353) into pGEX4T expression vector (Amersham
Biosciences). The MBP fusion protein was obtained by cloning ank1.5 (aa
22–155) into pMAL-c2X expression vector (New England Biolabs, Inc.).
Microsomes from mouse and rabbit skeletal muscles as well as from
HEK293 cells (transfected with ank1.5, ank1.7, and ank1.5 mut) were ob-
tained as previously described (Saito et al., 1984).
 
In vitro interaction studies and pull-down assay
 
The GST and MBP fusion proteins were expressed in XL1blue cells. The
cell lysates (PBS, 20 mM EDTA, 1% Triton X-100) were incubated for 20
min at 4
 
 
 
C with the resin to immobilize the fusion proteins; glutathione–
sepharose 4B beads (Amersham Biosciences) and maltose agarose beads
(New England Biolabs, Inc.) for GST and MBP, respectively. For binding ex-
periments, 5 
 
 
 
l of TnT protein extract was incubated with 15 
 
 
 
g of fusion
protein (50 
 
 
 
l of beads, 50% slurry) in interaction buffer (PBS, 1% Triton
X-100, 1% BSA) for 1 h at 4
 
 
 
C. A total of 250 
 
 
 
g of protein from micro-
somes was used in pull-down experiments. The interactions with the fusion
proteins (GST for transfected HEK293 and MBP for mouse skeletal muscle
microsomes) were performed in PBS, 0.2 mM PMSF, 1% Triton X-100 for
2 h at 4
 
 
 
C. Beads were washed in PBS, 1% Triton X-100. Proteins eluted in
SDS, 
 
 
 
-mercaptoethanol sample buffer were separated by SDS-PAGE.
 
Cell cultures, DNA transfection, 
and immunofluorescence staining
 
HEK 293 and NIH 3T3 cells were maintained in 
 
 
 
-MEM medium supple-
mented with 2 mM glutamine (Bio-Whittaker), 100 
 
 g/ml streptomycin, 100
U/ml penicillin (Bio-Whittaker), 1 mM sodium pyruvate (Bio-Whittaker), 10%
heat-inactivated fetal calf serum (Bio-Whittaker) at 37 C under 5% CO2.
Cultures of skeletal muscle cells were prepared from hind leg muscles of
newborn rats. In brief, the muscles were minced and subjected to three
successive treatments with 0.125% trypsin. Cells were resuspended in
DME plus 10% heat-inactivated fetal calf serum and plated onto gelatin-
coated coverslips. After 2 d, cells were transfected with appropriated con-
structs and then switched to differentiating media (i.e., DME supplemented
with 2% horse serum) for 3–6 d. DNA transfections were performed using
the Lipofectamine-Plus method (Invitrogen), following the manufacturer’s
instructions. Cells were fixed with 3% paraformaldehyde, 2% sucrose in
PBS (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM KH2PO4) for
10 min at room temperature, washed, and incubated for 15 min in 5%
goat serum in PBS. After washing, cells were permeabilized with Hepes
Triton buffer (20 mM Hepes, pH 7.4, 300 mM sucrose, 50 mM NaCl, 3
mM MgCl2, 0.5% Triton X-100). For ankyrin detection, cells were incu-
bated for 1 h at room temperature with an anti-myc monoclonal antibody
at a 1:1,000 dilution. Cy3-conjugated anti–mouse secondary antibodies
were from Jackson ImmunoResearch Laboratories and were used accord-
ing to the manufacturer’s instructions. Antibodies against obscurin were
prepared by injection of rabbits with a fusion protein containing aa 6215–
6353 of obscurin in frame with GST as previously described (Giannini et
al., 1995). Images were collected with an epifluorescence Axioplan 2 im-
aging microscope (Carl Zeiss MicroImaging, Inc.) equipped with a Micro-
MAX digital CCD camera (Princeton Instruments), digitized, stored, and
subsequently processed with Meta Imaging Series 4.5 software (Universal
Imaging Corp.).
This work was supported by grants from Telethon (GP0168Y02), Minis-
tero dell’Istruzione dell’Università e della Ricerca, Agenzia Spaziale Ital-
iana, European Community (HPRN-CT-2002-00331), and the University
of Siena.
Submitted: 19 August 2002
Revised: 9 December 2002
Accepted: 10 December 2002
References
Bang, M.L., T. Centner, F. Fornoff, A.J. Geach, M. Gotthardt, M. McNabb, C.C.
Witt, D. Labeit, C.C. Gregorio, H. Granzier, and S. Labeit. 2001. The com-
plete gene sequence of titin, expression of an unusual approximately 700-
kDa titin isoform, and its interaction with obscurin identify a novel Z-line
to I-band linking system. Circ. Res. 89:1065–1072.
Baumann, O., and B. Walz. 2001. Endoplasmic reticulum of animal cells and its
organization into structural and functional domains. Int. Rev. Cytol. 205:
149–214.
Beck, K.A., J.A. Buchanan, and W.J. Nelson. 1997. Golgi membrane skeleton:
identification, localization and oligomerization of a 195 kDa ankyrin iso-
form associated with the Golgi complex. J. Cell Sci. 110:1239–1249.
Bellin, R.B., T.W. Huiatt, D.R. Critchley, and R.M. Robson. 2001. Synemin may
function to directly link muscle cell intermediate filaments to both myo-
fibrillar Z-lines and costameres. J. Biol. Chem. 276:32330–32337.
Bennett, V., and A.J. Baines. 2001. Spectrin and ankyrin-based pathways: meta-
zoan invenctions for integrating cells into tissues. Physiol. Rev. 81:1353–
1392.
Berridge, M.J., P. Lipp, and M.D. Bootman. 2000. The versatility and universality
of calcium signalling. Nat. Rev. Mol. Cell Biol. 1:11–21.
Birkenmeier, C.S., J.J. Sharp, E.J. Gifford, S.A. Deveau, and J.E. Barker. 1998. An
alternative first exon in the distal end of the erythroid ankyrin gene leads to
production of a small isoform containing an NH2-terminal membrane an-
chor. Genomics. 50:79–88.
Blake, D.J., A. Weir, S.E. Newey, and K.E. Davies. 2002. Function and genetics of
dystrophin and dystrophin-related proteins in muscle. Physiol. Rev. 82:291–
329.
Devarajan, P., P.R. Stabach, A.S. Mann, T. Ardito, M. Kashgarian, and J.S. Mor-
row. 1996. Identification of a small cytoplasmic ankyrin (AnkG119) in the
kidney and muscle that binds  I  spectrin and associates with the Golgi ap-
paratus. J. Cell Biol. 133:819–830.
Epstein, H.F., and D.A. Fischman. 1991. Molecular analysis of assembly in muscle
development. Science. 251:1039–1044.
Flucher, B.E., and C. Franzini-Armstrong. 1996. Formation of junctions involved
in excitation-contraction coupling in skeletal and cardiac muscle. Proc. Natl.
Acad. Sci. USA. 93:8101–8106.
Flucher, B.E., M.E. Morton, S.C. Froehner, and M.P. Daniels. 1990. Localization
of the  1 and  2 subunits of the dihydropyridine receptor and ankyrin in
skeletal muscle triads. Neuron. 5:339–351.
Flucher, B.E., H. Takekura, and C. Franzini-Armstrong. 1993. Development of
the excitation-contraction coupling apparatus in skeletal muscle: association
of sarcoplasmic reticulum and transverse tubules with myofibrils. Dev. Biol.
160:135–147.
Franzini-Armstrong, C. 1994. The sarcoplasmic reticulum and the transverse
tubules.  In Myology. A.E. Engel and C. Franzini-Armstrong, editors.
McGraw-Hill Inc., New York. 176–199.
Furukawa, T., Y. Ono, H. Tsuchiya, Y. Katayama, M.L. Bang, D. Labeit, S. La-
beit, N. Inagaki, and C.C. Gregorio. 2001. Specific interaction of the potas-
sium channel  -subunit minK with the sarcomeric protein T-cap suggests a
T-tubule-myofibril linking system. J. Mol. Biol. 313:775–784.
Gagelin, C., B. Constantin, C. Deprette, M.A. Ludosky, M. Recouvreur, J. Car-
taud, C. Cognard, G. Raymond, and E. Kordeli. 2002. Identification of
AnkG107, a muscle-specific ankyrinG isoform. J. Biol. Chem. 277:12978–
12987.
Gallagher, P.G., and B.G. Forget. 1998. An alternate promoter directs expression
of a truncated, muscle-specific isoform of the human ankyrin 1 gene. J. Biol.
Chem. 273:1339–1348.
Giannini, G., A. Conti, S. Mammarella, M. Scrobogna, and V. Sorrentino. 1995.
The ryanodine receptor/calcium channel genes are widely and differentially
expressed in murine brain and peripheral tissues. J. Cell Biol. 128:893–904.
Golovina, V.A., and M.P. Blaustein. 1997. Spatially and functionally distinct Ca
2 
stores in sarcoplasmic and endoplasmic reticulum. Science. 275:1643–1648.
Gregorio, C.C., and P.B. Antin. 2000. To the heart of myofibril assembly. Trends
Cell Biol. 10:355–362.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
Ankyrin-1 binds obscurin in muscle cells | Bagnato et al. 253
Hoock, T.C., L.L. Peters, and S.E. Lux. 1997. Isoforms of Ankyrin-3 that lack the
NH2-terminal repeats associate with mouse macrophage lysosomes. J. Cell
Biol. 136:1059–1070.
Ito, K., S. Komazaki, K. Sasamoto, M. Yoshida, M. Nishi, K. Kitamura, and H.
Takeshima. 2001. Deficiency of triad junction and contraction in mutant
skeletal muscle Junctophilin type 1. J. Cell Biol. 154:1059–1067.
Kordeli, E., M.A. Ludosky, C. Deprette, T. Frappier, and J. Cartaud. 1998. Anky-
rinG is associated with the postsynaptic membrane and the sarcoplasmatic
reticulum in the skeletal muscle fiber. J. Cell Sci. 111:2197–2207.
Meldolesi, J., and T. Pozzan. 1998. The heterogeneity of ER Ca
2  stores has a key
role in nonmuscle cell signaling and function. J. Cell Biol. 142:1395–1398.
Mohler, P.J., A.O. Gramolini, and V. Bennett. 2002. The ankyrin-B C-terminal
domain determines activity of ankyrin-B/G chimeras in rescue of abnormal
inositol 1,4,5-trisphosphate and ryanodine receptor distribution in anky-
rin-B ( / ) neonatal cardiomyocytes. J. Biol. Chem. 277:10599–10607.
Nishi, M., S. Komazaki, N. Kurebayashi, Y. Ogawa, T. Noda, M. Iino, and H.
Takeshima. 1999. Abnormal features in skeletal muscle from mice lacking
Mitsugumin29. J. Cell Biol. 147:1473–1480.
Pan, Z., D. Yang, R.Y. Nagaraj, T.A. Nosek, M. Nishi, H. Takeshima, H. Cheng,
and J. Ma. 2002. Dysfunction of store-operated calcium channel in muscle
cells lacking mg29. Nat. Cell Biol. 4:379–383.
Pardo, J.V., J.D. Siliciano, and S.W. Craig. 1983. A vinculin-containing cortical
lattice in skeletal muscle: transverse lattice elements (“costamers”) mark sites
of attachment between myofibrils and sarcolemma. Proc. Natl. Acad. Sci.
USA. 80:1008–1012.
Peters, L.L., K.M. John, F.M. Lu, E.M. Eicher, A. Higgins, M. Yialamas, L.C.
Turtzo, A.J. Otsuka, and S.E. Lux. 1995. Ank3 (epithelial ankyrin), a widely
distributed new member of the ankyrin gene family and the major ankyrin
in kidney, is expressed in alternatively spliced forms, including forms that
lack the repeat domain. J. Cell Biol. 130:313–330.
Petersen, O.P., A. Tepikin, and M.K. Park. 2001. The endoplasmic reticulum: one
continuous or several separate Ca
2  stores? Trends Neurosci. 24:271–276.
Russell, M.W., M.O. Raeker, K.A. Korytkowski, and K.J. Sonneman. 2002. Iden-
tification, tissue expression and chromosomal localization of human Ob-
scurin-MLCK, a member of the titin and Dbl families of myosin light chain
kinases. Gene. 282:237–246.
Saito, A., S. Seiler, A. Chu, and S. Fleischer. 1984. Preparation and morphology of
sarcoplasmic reticulum terminal cisternae from rabbit skeletal muscle. J. Cell
Biol. 99:875–885.
Salanova, M., G. Priori, V. Barone, E. Intravaia, B. Flucher, F. Ciruela, R.A.J.
McIlhinney, J.B. Parys, K. Mikoshiba, and V. Sorrentino. 2002. Homer
proteins and InsP3 receptors co-localize in the longitudinal sarcoplasmic
reticulum of skeletal muscle fibers. Cell Calcium. 32:193–200.
Stromer, M.H. 1998. The cytoskeleton in skeletal, cardiac and smooth muscle
cells. Histol. Histopathol. 13:283–291.
Takeshima, H., S. Komazaki, M. Nishi, M. Iino, and K. Kangawa. 2000. Juncto-
philins: A novel family of junctional membrane complex proteins. Mol. Cell.
6:11–22.
Tuvia, S., M. Buhusi, L. Davis, M. Reedy, and V. Bennett. 1999. Ankyrin-B is re-
quired for intracellular sorting of structurally diverse Ca
2  homeostasis pro-
teins. J. Cell Biol. 147:995–1007.
Young, P., E. Ehler, and M. Gautel. 2001. Obscurin, a giant sarcomeric Rho gua-
nine nucleotide exchange factor protein involved in sarcomere assembly. J.
Cell Biol. 154:123–136.
Zhou, D., C.S. Birkenmeier, M.W. Williams, J.J. Sharp, J.E. Barker, and R.J.
Bloch. 1997. Small, membrane-bound, alternatively spliced forms of
ankyrin 1 associated with the sarcoplasmatic reticulum of mammalian skele-
tal muscle. J. Cell Biol. 136:621–631.